The use of pharmacotherapy with high-risk sex offenders

Managing high risk sex offenders in the community: Risk management, treatment and social responsibility

Volumn , Issue , 2010, Pages 105-132

  Harrison, Karen ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888679282     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (91)

1. Acampora (2003) The Structure, Properties, Function, and Synthesis of Serotonin and Serotonin's Similarity to LSD [online]. Available at: http://www.totse.com/en/technology/science:technology/seroton.html (accessed 16 March 2009).
2. Adi, Y., Ashcroft, D., Browne, K., Beech, A., Fry-Smith, A. and Hyde, C. (2002) Clinical Effectiveness and Cost-consequence of Selective Serotonin Reuptake Inhibitors in the Treatment of Sex Offenders. London: Home Office.
3. Aschwanden, R. and Ermer, A. (2008a) 'Leuprorelin Allergy as a Side Effect of Chemical Castration and, as a Consequence, the Discussion About Surgical Castration'. IATSO Conference, Capetown, August 2008.
4. Aschwanden, R. and Ermer, A. (2008b) 'The Impressive Effectiveness of Chemical Castration with Leuprorelin on a Homosexual Sadistic and Schizoid Sexual Murderer with Elimination of the Previously Dominating Sadistic Thoughts and Drive'. IATSO Conference, Capetown, August 2008.
5. Bain, J., Langevin, R., Hucker, S., Dickey, R., Wright, P. and Schonberg, C. (1988) 'Sex Hormones in Paedophiles, 1: Baseline Values of Six Hormones, 2: The Gonadotropin Releasing Hormone Test', Sexual Abuse: A Journal of Research and Treatment, 1(3): 443-54.
6. Baker, W. L. (1984) 'Castration of the Male Sex Offender: A Legally Impermissible Alternative', Loyola Law Review, 30: 377-399.
7. Beech, A. R. and Mitchell, I. J. (2005) 'A Neurobiological Perspective on Attachment Problems in Sexual Offenders and the Role of Selective Serotonin Reuptake Inhibitors in the Treatment of Such Problems', Clinical Psychology Review, 25: 153-182.
8. Berlin, F. S. (1994) 'The Case for Castration, Part 2', Washington Monthly, 26(5): 28.
9. Berlin, F. S. and Meinecke, C. (1981) 'Treatment of Sex Offenders with Antiandrogenic Medication: Conceptualization, Review of Treatment Modalities and Preliminary Findings', American Journal of Psychiatry, 138(5): 601-607.
10. Bowden, P. (1991) 'Treatment: Use, Abuse and Consent', Criminal Behaviour and Mental Health, 1: 130-141.
11. Bradford, J. W. (1983) 'The Hormonal Treatment of Sexual Offenders', Bulletin of the American Academy of Psychiatry and the Law, 11: 159-169.
12. Bradford, J. M. W. and Pawlak, A. (1993) 'Double-Blind Placebo Crossover Study of Cyproterone Acetate in the Treatment of the Paraphilias', Archives of Sexual Behavior, 22(5): 383-402.
13. Briken, P. (2002) 'Pharmacotherapy with Luteinizing Hormone-releasing Hormone Agonists', Archives of General Psychiatry, 59: 469-470.
14. Briken, P., Hill, A. and Berner, W. (2003) 'Pharmacotherapy of Paraphilias with Long-acting Agonists of Luteinizing Hormone-releasing Hormone: A Systematic Review', Journal of Clinical Psychiatry, 64(8): 890-897.
15. Briken, P., Nika, E. and Berner, W. (2001) 'Treatment of Paraphilia with Luteinising Hormone-releasing Agonists', Journal of Sex and Marital Therapy, 27: 45-55.
16. Brody, A. L. and Green, R. (1994) 'Washington States' Unscientific Approach to the Problem of Repeat Sex Offenders', Bulletin of the American Academy of Psychiatry and the Law, 20: 343-356.
17. Carpenter, A. (1998) 'Belgium, Germany, England, Denmark and the United States: The Implementation of Registration and Castration Laws as Protection Against Habitual Sex Offenders', Dickinson Journal of International Law, 16(2): 435-457.
18. Christie, N. (1982) Limits to Pain. Oxford: Robertson.
19. Connelly, C. and Williamson, S. (2000) A Review of the Research Literature on Serious Violent and Sexual Offenders. Edinburgh: Scottish Executive Central Research Unit.
20. Cooper, A. J. (1981) 'A Placebo-controlled Trial of the Anti-Androgen Cyproterone Acetate in Deviant Hypersexuality', Comprehensive Psychiatry, 22(5): 458-465.
21. Cooper, A. J., Ismail, A. A. A., Phanjoo, A. L. and Love, D. L. (1972) 'Antiandrogen (Cyproterone Acetate) Therapy in Deviant Hypersexuality', British Journal of Psychiatry, 120: 59-63.
22. Cooper, A. J., Sandhu, S., Losztyn, S. and Cernovsky, Z. (1992) 'A Double-Blind Placebo Controlled Trial of Medroxyprogesterone Acetate and Cyproterone Acetate with Seven Pedophiles', Canadian Journal of Psychiatry, 3: 687-693.
23. Craissati, J. (2004) Managing High Risk Sex Offenders in the Community. A Psychological Approach. New York: Routledge.
24. Czerny, J. P., Briken, P. and Berner, W. (2002) 'Antihormonal Treatment of Paraphilic Patients in German Forensic Psychiatric Clinics', European Psychiatry, 17: 104-106.
25. Davis, T. S. (1974) 'Cyproterone Acetate for Male Hypersexuality', Journal of International Medical Research, 2: 159-163.
26. Department of Health (2009) NHS Costs and Exemptions [online]. Available at: http://www.dh.gov.uk/en/Healthcare/Medicinespharmacyandindustry/Prescriptions/NHScosts/index.htm (accessed 16 February 2009).
27. Dickey, R. (2002) 'Case Report: The Management of Bone Demineralization Associated with Long-Term Treatment of Multiple Paraphilias with Long-Acting LNRH Agonists', Journal of Sex and Marital Therapy, 28: 207-210.
28. Dunn, C. W. (1940) 'Stilboestrol Induced Gynaecomastia in the Male', Journal of the American Medical Association, 115: 2263-2264.
29. Fitzgerald, E. (1990) 'Chemical Castration: MPA Treatment of the Sexual Offender ', American Journal of Criminal Law, 18(1): 1-60.
30. Foote, R. M. (1944) 'Hormonal Treatment of Sex Offenders', Journal of Nervous and Mental Disorders, 99: 928-929.
31. Frenken, J., Gijs, L. and Van Beek, D. (1999) 'Sexual Offender Research and Treatment in the Netherlands', Journal of Interpersonal Violence, 14(4): 347-371.
32. Gaffney, G. and Berlin, F. (1984) 'Is There a Hypothalamic-Pituitary-Gonadal Dysfunction in Paedophilia? A Pilot Study', British Journal of Psychiatry, 145: 657-660.
33. Gagne, P. (1981) 'Treatment of Sex Offenders with Medroxyprogesterone Acetate', American Journal of Psychiatry, 138: 644-646.
34. Greenberg, D. M. and Bradford, J. M. (1997) 'Treatment of the Paraphilic Disorders: A Review of the Role of the Selective Serotonin Reuptake Inhibitors', Sexual Abuse: A Journal of Research and Treatment, 9(4): 349-360.
35. Greenberg, D. M., Bradford, J. M., Curry, S. and O'Rourke, A. (1996) 'A Comparison of Treatment of Paraphilias with Three Serotonin Reuptake Inhibitors: A Retrospective Study', Bulletin of the American Academy of Psychiatry Law, 24(4): 525-532.
36. Grossman, L. S., Martis, B. and Fichtner, C. G. (1999) 'Are Sex Offenders Treatable? A Research Overview', Psychiatric Services, 50(3): 349-361.
37. Grubin, D. (2007) Second Expert Paper: Sex Offender Research, NHS National Programme on Forensic Mental Health Research and Development. Liverpool: Forensic Mental Health.
38. Grubin, D. (2008) 'The Use of Medication in the Treatment of Sex Offenders', Prison Service Journal, 178: 37-43.
39. Gys, L. and Gooren, L. (1996) 'Hormonal and Psychopharmacological Interventions in the Treatment of Paraphilias: An Update', Journal of Sex Research, 33(4): 273-290.
40. Harrison, K. (2007) 'The High Risk Sex Offender Strategy in England and Wales: Is Chemical Castration an Option?', Howard Journal, 46(1): 16-31.
41. Harrison, K. (2008) 'Legal and Ethical Issues When Using Antiandrogenic Pharmacotherapy with Sex Offenders', Sexual Offender Treatment, 3(2) [online]. Available at http://www.sexual-offender-treatment.org/2-2008_01.html (accessed 29 July 2008).
42. Harrison, K. and Rainey, B. (2009) 'Suppressing Human Rights? A Rights-Based Approach to the Use of Pharmacotherapy with Sex Offenders', Legal Studies, 29(1): 47-74.
43. Heller, C. G., Laidlaw, W. M., Harvey, H. T. and Nelson, W. O. (1958) 'Effects of Progestational Compounds on the Reproductive Processes of the Human Male', Annals of the New York Academy of Sciences, 71: 649-665.
44. Hicks, P. (1993) 'Castration of Sexual Offenders: Legal and Ethical Issues', Journal of Legal Medicine, 14: 641-667.
45. Home Office (2007) Review for the Protection of Children from Sex Offenders. London: Home Office.
46. Hutton, E. L. and Reiss, M. (1942) 'The Hormone Treatment of Acromegaly', Journal of Mental Science, 88: 550-553.
47. Icenogle, D. L. (1994) 'Sentencing Male Sex Offenders to the Use of Biological Treatments. A Constitutional Analysis', Journal of Legal Medicine, 15: 279-304.
48. Kafka, M. P. (1997) 'A Monoamine Hypothesis for the Pathophysiology of Paraphilic Disorders', Archives of Sexual Behavior, 26(4): 343-358.
49. Kafka, M. P. (2001) 'The Role of Medications in the Treatment of Paraphiliarelated Disorders', Sexual and Relationship Therapy, 16(2): 105-112.
50. Kafka, M. P. (2006) 'Pharmacological Treatments for Sexual Offenders: How Can We Reduce Sexual Motivation and Impulsivity Associated with Sexual Offending?', IATSO conference, Hamburg, 2006.
51. Kafka, M. P. and Coleman, E. (1991) 'Serotonin and Paraphilias: The Convergence of Mood, Impulse and Compulsive Disorders', Journal of Clinical Psychopharmacology, 11: 223-224.
52. Krueger, R. B. and Kaplan, M. S. (2001) 'Depot-Leuprolide Acetate for Treatment of Paraphilias: A Report of Twelve Cases', Archives of Sexual Behaviour, 30(4): 409-422.
53. Kruesi, M. J. P., Fine, S., Valladares, L., Phillips, R. A. Jr. and Rapoport, J. L. (1992) 'Paraphilias: A Double-Blind Crossover Comparison of Clomipramine Versus Desipramine', Archives of Sexual Behavior, 21(6): 587-593.
54. Leiblum, S. R. and Rosen, R. C. (1988) 'Changing Perspectives on Sexual Desire', in S. R. Leiblum and R. C. Rosen (eds), Sexual Desire Disorders. New York: Guilford Press.
55. Lockhart, L. L., Saunders, B. E. and Cleveland, P. (1989) 'Adult Male Sexual Offenders: An Overview of Treatment Techniques' in J. S. Wodarski and D. L. Whitaker (eds), Treatment of Sex Offenders in Social Work and Mental Health Settings. Philadelphia: Haworth Press.
56. Maletzky, B. M. (1980) 'Self-Referred Versus Court-referred Sexually Deviant Patients: Success with Assisted Covert Sensitization', Behavior Therapy, 11: 306-314.
57. Maletzky, B. M. and Field, G. (2003) 'The Biological Treatment of Dangerous Sexual Offenders: A Review and Preliminary Report of the Oregon Pilot Depo-Provera Program', Aggression and Violent Behavior, 8: 391-412.
58. Maletzky, B. M., Tolan, A. and McFarland, B. (2006) 'The Oregon Depo-Provera Program: A Five-Year Follow-Up', Sex Abuse, 18: 303-316.
59. Melella, J. T., Travin, S. and Cullen, K. (1989) 'Legal and Ethical Issues in the Use of Anti-Androgens in Treating Sex Offenders', Bulletin of the American Academy of Psychiatry and the Law, 17(3): 223-31.
60. Meyer, W. J. and Cole, C. M. (1997) 'Physical and Chemical Castration of Sex Offenders: A Review', Journal of Offender Rehabilitation, 25(3/4): 1-18.
61. Meyer, W. J., Cole, C. and Emory, E. (1992) 'Depo-Provera Treatment for Sex Offending Behavior: An Evaluation of Outcome', Bulletin of the American Academy of Psychiatry and the Law, 20(3): 249-259.
62. Miller, R. D. (1998) 'Forced Administration of Sex-Drive Reducing Medications to Sex Offenders: Treatment or Punishment?', Psychology, Public Policy and Law, 4(1/2): 175-199.
63. Money, J. M. (1970) 'Use of Androgen-Depleting Hormone in the Treatment of Sex Offenders', Journal of Sex Research, 6: 167-172.
64. Money, J. M. (1972) 'The Therapeutic Use of Androgen-Depleting Hormone', International Psychiatry Clinics, 8: 165-174.
65. Money, J. M. (1979) 'Ideas and Ethics of Psychosexual Determinism', British Journal of Sexual Medicine, May: 27-32.
66. Money, J. M. (1987) 'Treatment Guidelines: Anti-androgen and Counselling of Paraphilic Sex Offenders', Journal of Sex and Marital Therapy, 13(3): 219-223.
67. Money, J., Wiedeking, C., Walker, P. A. and Gain, D. (1976) 'Combined Antiandrogenic and Counselling Program for Treatment of 46, XY and 47, XYY Sex Offenders', in E. J. Sachar (ed.), Hormones, Behavior and Psychopathology. New York: Raven.
68. Munafo, R. (1994) Sex Offender Treatment Project: Literature Review. University of Alaska Anchorage: Justice Center.
69. Murphy, C. (2007) 'Can Drugs Help Sex Offenders?', BBC News [online]. Available at: http://news.bbc.co.uk/1/hi/uk/6748789.stm (accessed 18 July 2008).
70. NetDoctor (2008) Androcur [online]. Available at: http://www.netdoctor.co.uk/medicines/100000131.html (accessed 29 July 2008).
71. NOMS (2007) Medical Treatment for Sex Offenders. Probation Circular 35/2007. London: NOMS.
72. Ortmann, J. (1980) 'The Treatment of Sexual Offenders: Castration and Antihormone Therapy', International Journal of Law and Psychiatry, 3: 443-51.
73. Pearson, H. J. (1990) 'Paraphilias, Impulse Control, and Serotonin', Journal of Clinical Psychopharmacology, 10: 233.
74. Polak, M. A. and Nijman, H. (2005) 'Pharmacological Treatment of Sexually Aggressive Forensic Psychiatric Patients', Psychology, Crime and Law, 11(4): 457-465.
75. Prentky, R. A. (1997) 'Arousal Reduction in Sexual Offenders. A Review of Antiandrogen Interventions', Sexual Abuse: A Journal of Research and Treatment, 9(4): 335-347.
76. Prentky, R. and Burgess, A. W. (1990) 'Rehabilitation of Child Molesters: A Cost-Benefit Analysis', American Journal of Orthopsychiatry, 60(1): 108-117.
77. Rieber, I. and Sigusch, V. (1979) 'Psychosurgery on Sex Offenders and Sexual "Deviants" in West Germany', Archives of Sexual Behavior, 8(6): 523-527.
78. Rösler, A. and Witztum, E. (1998) 'Treatment of Men with Paraphilia with a Long-Acting Analogue of Gonadotropin-releasing Hormone', New England Journal of Medicine, 338: 416-422.
79. Rösler, A. and Witztum, E. (2000) 'Pharmacotherapy of the Paraphilias in the Next Millennium', Behavioral Sciences and the Law, 18: 43-56.
80. Rousseau, L., Couture, M., Dupont, A., Labrie, F. and Couture, N. (1990) 'Effect of Combined Androgen Blockade with an LHRH Agonist and Flutamide in One Severe Case of Male Exhibitionism', Canadian Journal of Psychiatry, 35(4): 338-341.
81. Russell, S. (1997) 'Castration of Repeat Sexual Offenders: An International Comparative Analysis', Houston Journal of International Law, 19: 425-459.
82. Saleh, F. (2005) 'A Hypersexual Paraphilic Patient Treated with Leuprolide Acetate: A Single Case Report', Journal of Sex and Marital Therapy, 31: 433-444.
83. Saleh, F. M., Niel, T. and Fishman, M. J. (2004) 'Treatment of Paraphilia in Young Adults with Leuprolide Acetate: A Preliminary Case Report Series', Journal of Forensic Science, 49(6): 1343-1348.
84. Schober, J. M., Kuhn, P. J., Kovacs, P., Earle, J., Byrne, P. and Fries, R. (2005) 'Leuprolide Acetate Suppresses Pedophilic Urges and Arousability', Archives of Sexual Behavior, 34: 691-705.
85. Sim, J. (1990) Medical Power in Prisons: The Prison Medical Service in England 1774-1989. Buckingham: Open University Press.
86. Stone, T. H., Winslade, W. J. and Klugman, C. M. (2000) 'Sex Offenders, Sentencing Laws and Pharmaceutical Treatment: A Prescription for Failure', Behavioral Sciences and the Law, 18: 83-110.
87. Thibaut, F. Cordier, B. and Kuhn, J.-M. (1996) 'Gonadotropin Hormone Releasing Hormone Agonist in Cases of Severe Paraphilia: A Lifetime Treatment?', Psychoneuroendocrinology, 21(4): 411-119.
88. Weiss, P. (1999) 'Assessment and Treatment of Sex Offenders in the Czech Republic and in Eastern Europe', Journal of Interpersonal Violence, 14(4): 411-421.
89. Wille, R. and Beier, K. (1989) 'Castration in Germany', Annals of Sex Research, 2: 103-133.
90. Wincze, J. P., Bansal, S. and Malamud, M. (1986) 'Effects of Medroxyprogesterone Acetate on Subjective Arousal, Arousal to Erotic Stimulation, and Nocturnal Penile Tumescence in Male Sex Offenders', Archives of Sexual Behaviour, 15(4): 293-305.
91. Zohar, J., Kaplan, Z. and Benjamin, J. (1994) 'Compulsive Exhibitionism Successfully Treated with Fluvoxamine: A Controlled Case Study', Journal of Clinical Psychiatry, 55(3): 86-88.